Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06870812 · ClinicalTrials.gov registry record · NA
Rapid Evacuation and Access of Cerebral Hemorrhage Trial
A NA study of Stroke Hemorrhagic, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 20
- Study locations
NCT06870812: Recruiting NA study of Stroke Hemorrhagic, sponsored by Emory University.
NCT06870812 is a NA study of Stroke Hemorrhagic that is actively recruiting participants, run by Emory University. The registered enrollment target is 600 participants, above the 56-participant average among 6 other Stroke Hemorrhagic trials with a reported enrollment target (971% higher). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06870812, a NA study of Stroke Hemorrhagic, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 20
- Study locations
Study Summary
The main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard treatment involves admission to the Intensive Care Unit (ICU) with close monitoring and blood pressure control. It also includes other medical (non-surgical) treatments to prevent more bleeding or another stroke. Sometimes, doctors will recommend surgery to remove the blood if medical treatment alone is not successful. There is evidence that doing minimally invasive surgery early-using a small opening in the skull to remove blood-may help some patients. Researchers aim to understand whether this surgery is better than current medical treatment, which may include surgeries to relieve pressure on the brain in some cases. This study, called REACH, is comparing usual medical care to early minimally invasive surgery so doctors can know which is better for patients.
Primary Outcome
The mRS is a seven-level ordinal scale that ranges from 0 (no symptoms) to 6 (death).
Conditions Studied
Interventions
- OTHER Medical Management
- PROCEDURE Surgical management
Study Locations (20)
Florida
- Baptist Health Jacksonville FL - Jacksonville
- Baptist Health South Florida - Kendall
- Jackson Memorial Hospital (JMH) - Miami
Georgia
- Grady Memorial Hospital - Atlanta
- Emory Hospital Midtown - Atlanta
- Emory University Hospital (EUH) - Atlanta
New York
- Albany Medical Center - Albany
- SUNY Upstate Medical University - Syracuse
- Montefiore Medical Center/Albert Einstein School of Medicine - The Bronx
Illinois
- Rush University - Chicago
- Endeavor Health, Northshore - Evanston
Ohio
- The Ohio State University - Columbus
- ProMedica Toledo Hospital - Toledo
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
California
- Stanford University Medical Center - Palo Alto
Indiana
- Goodman Campbell Brain and Spine - Carmel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2025-05-27 |
| Est. Completion | 2030-03 |
| Phase | NA |
What NCT06870812 shows while recruiting
NCT06870812 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 56-participant average among 6 other Stroke Hemorrhagic trials with a reported enrollment target (971% higher).
The record links to 1 condition, with Stroke Hemorrhagic appearing as the primary indexed condition, and to 2 interventions - of which Medical Management is the first listed.
NCT06870812 names 20 study sites across 12 states, led by Florida, Georgia, New York.
Frequently Asked Questions
What is clinical trial NCT06870812 about?
NCT06870812 is a clinical study titled "Rapid Evacuation and Access of Cerebral Hemorrhage Trial". The main purpose of this study is to compare patients with a deep bleed in the brain undergoing surgery to patients receiving routine medical care. The standard treatment involves admission to the Intensive Care Unit (ICU) with close monitoring and blood pressure control. It also includes other medi...
What is the current status of trial NCT06870812?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2025-05-27. Estimated completion is 2030-03.
What conditions does trial NCT06870812 study?
This clinical trial studies the following conditions: Stroke Hemorrhagic.
What interventions are being tested in trial NCT06870812?
The interventions under investigation include: Medical Management (OTHER), Surgical management (PROCEDURE).
Who is sponsoring clinical trial NCT06870812?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06870812 being conducted?
This trial has 20 study locations across Arkansas, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke Hemorrhagic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Utility of CC7 Transfer in Stroke Subtypes
RECRUITING · NA
-
The REACTplusNMES Trial: A Double-blinded RCT
RECRUITING · NA
-
At-Home taVNS - Stroke Rehab
RECRUITING · NA
-
Ischemic Conditioning Improves Walking Function Post Stroke
RECRUITING · NA
-
Behavioral Activation for Post-Stroke Sedentary Behavior Using Telehealth
COMPLETED · NA
-
Promoting Recovery After STroke With Amantadine
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI